Skip to main content

Table 4 Summary of studies on cytoreductive surgery of recurrent endometrial cancer

From: Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study

 

Case

PFI (m)

Surgery patients

OS (m)

Optimal definition (cm)

Optimal cytoreduction (%)

Optimal median OS (m)

Suboptimal median OS (m)

Scarabelli [7]

20

16.9

20

NA

No gross

65 (13/20)

12

Undefined

Campagnutta [8]

75

13

75

19

<=1

74.7 (56/75)

53

9

Bristow [9]

61

18.5

35

28

No grossly visible

65.7 (23/35)

39

13.5

/

26

13

/

/

/

/

Awtrey [10]

27

20

27

35

<=2

67 (18/27)

43

10

This study

75

18

75

18

<=1

77.3(58/75)

72

22

  1. Note. NA, not assessable. PFI, progression free interval. OS, overall survival.